Novo Nordisk to slash Ozempic and Wegovy list prices by up to 50% for 2027

By Tami Luhby, CNN (CNN) — Battling to regain its market share over rival Eli Lilly, Novo Nordisk announced Tuesday that it will reduce the list prices of its popular weight loss drug Wegovy and diabetes drugs Ozempic and Rybelsus by up to half starting in 2027. The $675 monthly list price is aimed at